Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

340 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Completed

Immunomodulation With Eltrombopag in ITP

NCT04812483

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Aarau Cantonal Hospital, Division of Hematology Aarau, Switzerland
  • University Children's Hospital Basel (UKBB) Basel, Switzerland
  • University Hospital Basel, Division of Hematology Basel, Switzerland
  • University Hospital Bern, Division of Hematology Bern, Switzerland
View Trial Details
Completed

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

NCT05422365

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Municipal non-profit enterprise "City Clinical Hospital No. 4" of the Dnipro City Council Dnipro, Ukraine
  • Municipal non-profit enterprise "Khmelnytskyi Regional Hospital" of the Khmelnytskyi Regional Council Khmelnytskyi, Ukraine
  • Municipal Non-Profit Enterprise "Kirovohrad Regional Hospital of the Kirovohrad Regional Council" Kropyvnytskyi, Ukraine
  • Medical Center "OK!Clinic+" of the Company with Limited Liability "International Institute of Clinical Research" Kyiv, Ukraine
View Trial Details
Completed

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

NCT04056195

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California, 1441 Eastlake Ave. Los Angeles, California, United States
  • Duke University Medical Center, 2301 Erwin Road Durham, North Carolina, United States
  • East Carolina University, 600 Moye Boulevard Greenville, North Carolina, United States
  • The Cleveland Clinic Foundation, 9500 Euclid Avenue Cleveland, Ohio, United States
View all 27 locations
View Trial Details
Completed

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

NCT05492409

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Health of the Russian Federation Ufa, Bashkortostan Republic, Russia
  • State Budgetary Institution of Healthcare Irkutsk awarded the "Sign of Honor" Order Regional Clinical Hospital Irkutsk, Irkutsk Oblast, Russia
  • State Budgetary Health Institution of the Kaluga Region "Kaluga Regional Clinical Hospital" Kaluga, Kaluga Oblast, Russia
  • State budgetary institution of health care of the Nizhny Novgorod region "Nizhny Novgorod Regional Clinical Hospital named after N. A. Semashko" Nizhny Novgorod, Nizhny Novgorod Oblast, Russia
View all 13 locations
View Trial Details
Completed

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

NCT06408324

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Hôpital Universitaire Henri Mondor Créteil, France
  • CHU Dijon - Hôpital François Mitterrand Médecine 1 - Etudes Cliniques Dijon, France
  • CHU Toulouse - Hôtel-Dieu Saint-Jacques Toulouse, France
  • Careggi Hospital Florence, Italy
View all 17 locations
View Trial Details
Completed

Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)

NCT02868060

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Peking Union hospital Beijing, China
  • West China hospital Chengdu, China
  • Chinese academy of medical science hematology hospital Tianjin, China
  • Wuxi People's Hospital Wuxi, China
View Trial Details

Related conditions